Yusuf Khalil, MD

timeline

2025 -

Dermatology residency.

2024 - 2025

Transitional year residency (PGY-1).

2023 - 2024

Intern analyst at Readout Capital, a biotech investment fund.

2020 - 2024

MD from Northeast Ohio Medical University. During med school, I worked on VibeRx, exploring non-invasive wearables for Parkinson's motor symptoms.

2014 - 2019

BS from the University of Michigan.

bio

Yusuf Khalil is a dermatology resident with interests in biotech, investing, and building in healthcare.

projects

Working on something in biotech.

publications

• How We Do It: The MOHS Checklist for Additional Stages 2024
  Y. Khalil, H. Grubbs, A. K. Somani, and A. Abdulhak, Dermatol Surg., vol. 50, no. 5, pp. 488-489, 2024, doi: 10.1097/DSS.0000000000004102. PubMed
• Thyrotoxicosis-Induced Cardiomyopathy With Systolic Dysfunction 2023
  Y. Khalil, M. D. Dube, and L. Woods, Cureus, vol. 15, no. 1, e33988, 2023, doi: 10.7759/cureus.33988. PubMed
• Osteopathy in Complex Lymphatic Anomalies 2022
  E. Solorzano, A. L. Alejo, H. C. Ball, J. Magoline, Y. Khalil, et al., Int J Mol Sci., vol. 23, no. 15, pp. 1-15, 2022, doi: 10.3390/ijms23158258. PubMed
• A Pre-clinical Standard Operating Procedure for Evaluating Orthobiologics in an In Vivo Rat Spinal Fusion Model 2022
  A. L. Alejo, S. McDermott, Y. Khalil, et al., J Orthop Sports Med., vol. 4, no. 3, pp. 224-240, 2022, doi: 10.26502/josm.511500060.
• All Eyes on You: A Covert Observational Study on Contact Precaution Compliance in Six Hospitals at the Detroit Medical Center 2018
  S. Chandramohan, A. Krishna, B. Navalkele, Y. Khalil, et al., Open Forum Infect Dis., vol. 5, suppl_1, pp. S173-S174, 2018, doi: 10.1093/ofid/ofy210.471.

book list

books (still useful; i usually favor pre-2020 titles to avoid slop; not exhaustive.)

interests

Biotech investing, prediction markets, AI/ML in healthcare, medical devices, financial modeling, and building things.